Trametinib in histiocytic sarcoma with an activating MAP2K1 (MEK1) mutation - To the editor Journal Article
| Authors: | Gounder, M. M.; Solit, D. B.; Tap, W. D. |
| Article Title: | Trametinib in histiocytic sarcoma with an activating MAP2K1 (MEK1) mutation - To the editor |
| Keywords: | middle aged; genetics; mutation; case report; metabolism; mitogen activated protein kinase kinase 1; protein kinase inhibitor; diagnostic imaging; pyrimidinone derivative; pyridones; pyrimidinones; protein kinase inhibitors; mitogen activated protein kinase kinase; mitogen-activated protein kinase kinases; map kinase kinase 1; histiocytic sarcoma; metabolic networks and pathways; map2k1 protein, human; trametinib; pyridone derivative; humans; human; male; antagonists and inhibitors |
| Journal Title: | New England Journal of Medicine |
| Volume: | 378 |
| Issue: | 20 |
| ISSN: | 0028-4793 |
| Publisher: | Massachusetts Medical Society |
| Date Published: | 2018-05-17 |
| Start Page: | 1945 |
| End Page: | 1947 |
| Language: | English |
| DOI: | 10.1056/NEJMc1511490 |
| PUBMED: | 29768143 |
| PROVIDER: | scopus |
| PMCID: | PMC6062005 |
| DOI/URL: | |
| Notes: | Letter -- Export Date: 1 June 2018 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work